Gifford Fong Associates’s AbbVie ABBV Stock Holding History

Gifford Fong Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$6.38M	Hold	27,900	–	–	1.27%	24
2025 Q3	$6.46M	Hold	27,900	–	–	1.36%	21
2025 Q2	$5.18M	Hold	27,900	–	–	1.19%	24
2025 Q1	$5.85M	Hold	27,900	–	–	1.45%	17
2024 Q4	$4.96M	Hold	27,900	–	–	1.22%	21
2024 Q3	$5.51M	Hold	27,900	–	–	1.38%	16
2024 Q2	$4.79M	Hold	27,900	–	–	1.27%	17
2024 Q1	$5.08M	Hold	27,900	–	–	1.4%	16
2023 Q4	$4.32M	Hold	27,900	–	–	0.92%	31
2023 Q3	$4.16M	Hold	27,900	–	–	0.99%	26
2023 Q2	$3.76M	Hold	27,900	–	–	0.88%	32
2023 Q1	$4.45M	Hold	27,900	–	–	1.17%	22
2022 Q4	$4.51M	Hold	27,900	–	–	1.03%	29
2022 Q3	$3.74M	Hold	27,900	–	–	0.93%	27
2022 Q2	$4.27M	Hold	27,900	–	–	1%	26
2022 Q1	$4.52M	Hold	27,900	–	–	0.83%	32
2021 Q4	$3.78M	Hold	27,900	–	–	0.66%	38
2021 Q3	$3.01M	Hold	27,900	–	–	0.58%	45
2021 Q2	$3.14M	Hold	27,900	–	–	0.61%	43
2021 Q1	$3.02M	Hold	27,900	–	–	0.65%	44
2020 Q4	$2.99M	Hold	27,900	–	–	0.69%	38
2020 Q3	$2.44M	Hold	27,900	–	–	0.65%	36
2020 Q2	$2.74M	Hold	27,900	–	–	0.83%	32
2020 Q1	$2.13M	Hold	27,900	–	–	0.78%	36
2019 Q4	$2.47M	Hold	27,900	–	–	0.72%	37
2019 Q3	$2.11M	Buy	27,900 +10,000	+56%	+$686K	0.69%	40
2019 Q2	$1.3M	Hold	17,900	–	–	0.44%	65
2019 Q1	$1.44M	Hold	17,900	–	–	0.48%	57
2018 Q4	$1.65M	Hold	17,900	–	–	0.62%	47
2018 Q3	$1.69M	Hold	17,900	–	–	0.54%	52
2018 Q2	$1.66M	Hold	17,900	–	–	0.57%	48
2018 Q1	$1.69M	Buy	+17,900	New	+$1.97M	0.69%	42

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Gifford Fong Associates's ABBV Position: Q4 2025 in Review

Gifford Fong Associates held its AbbVie (ABBV) position steady in Q4 2025 at 27,900 shares worth $6.38M. The position accounts for 1.27% of the portfolio, ranked #24.

Gifford Fong Associates first reported a position in ABBV in Q1 2018 and has held it in 32 quarters since. The position peaked at $6.46M in Q3 2025. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Gifford Fong Associates held 27,900 shares of AbbVie worth $6.38M as of Q4 2025.
Gifford Fong Associates left its AbbVie share count unchanged in Q4 2025.
AbbVie made up 1.27% of Gifford Fong Associates's portfolio in Q4 2025, its #24 holding.
Gifford Fong Associates first reported a position in AbbVie in Q1 2018 and has held it in 32 quarters since.
Gifford Fong Associates's AbbVie position peaked at $6.46M in Q3 2025.
4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Gifford Fong Associates's 13F filing for Q4 2025, filed 10 Feb 2026.